Blast Crisis

This is a very advanced stage of a type of leukemia called chronic myelogenous leukemia (CML). It means there's a huge increase in immature blood cells (blasts) in the blood and bone marrow. This can cause serious problems like infections and bleeding.

Condition

What people with Blast Crisis report

Every report comes from a Lived member, sent anonymously.

Have you had Stem Cell Transplant for Blast Crisis?

NameHow it went

About Blast Crisis

What It Is

Blast crisis, also called blast phase, is the most advanced stage of chronic myeloid leukemia (CML), a cancer of the blood-forming cells in the bone marrow. In its usual chronic phase, CML grows slowly and is often well controlled with daily pills. In blast phase, it begins to behave like an acute leukemia: the marrow fills with blasts, immature white blood cells that multiply quickly but never mature into cells that can fight infection. Doctors usually define blast phase as 20% or more blasts in the blood or bone marrow, although some classification systems use 30%. As blasts crowd out normal marrow, people can develop anemia (too few red blood cells), infections and easy bleeding. Many also feel very tired and run fevers, and the spleen, an organ under the left ribs, may enlarge and cause fullness or pain there. Bone pain can also occur.

Causes & Risk Factors

Blast phase happens when CML cells pick up further genetic changes on top of the one that started the disease, the Philadelphia chromosome. That original change creates an abnormal gene, BCR-ABL1, that drives the leukemia. Over time, extra chromosome changes or new mutations can let the cells escape control and stop maturing. The Philadelphia chromosome and these later changes develop during a person's life; they are not inherited. Today, progression to an advanced phase is uncommon: it has fallen from more than 20% of people before modern targeted drugs to fewer than 5% now. The main situations in which it occurs are leukemia that stops responding to treatment (often because of a mutation that blocks the drug), CML that was never diagnosed or treated, and, in some people, gaps in taking daily medicine. Certain extra chromosome changes found at diagnosis also signal a higher risk. Some people are first diagnosed with CML when it is already in blast phase.

How It's Diagnosed

Diagnosis relies on blood counts and a bone marrow test, in which a small sample of marrow is taken with a needle. The key measurement is the percentage of blasts. Fewer than 10% is typical of chronic phase; 20% or more in the blood or marrow points to blast phase. Further tests guide treatment. Flow cytometry, a lab test that reads markers on the surface of cells, shows whether the blasts are myeloid (resembling acute myeloid leukemia) or lymphoid (resembling acute lymphoblastic leukemia). This matters because the two are treated differently, and lymphoid blast phase has more treatment options and a better outlook. Chromosome testing looks for new changes, and sequencing of the BCR-ABL1 gene looks for mutations that make particular targeted drugs ineffective.

Treatment Options

Blast phase needs prompt treatment at a center experienced in leukemia, ideally one that performs stem cell transplants. The usual plan has two steps. First, treatment tries to push the leukemia back into a chronic phase. Second, for people well enough, an allogeneic stem cell transplant (blood-forming cells from a matched donor) follows without delay, because it offers the best chance of long-term control. Transplant is generally not done while the disease is still in active blast phase. The first step combines a tyrosine kinase inhibitor (TKI), a targeted pill that blocks the BCR-ABL1 signal, with chemotherapy matched to the blast type: regimens used for acute myeloid leukemia in myeloid blast phase, or for acute lymphoblastic leukemia in lymphoid blast phase. The TKI is chosen by what the person has taken before and by mutation testing. Options include imatinib (Gleevec), second-generation drugs such as dasatinib, and ponatinib (Iclusig), a more potent TKI that works against some resistant mutations. Ponatinib carries a higher risk of blocked arteries, blood clots and heart failure, which weighs in the choice for people with heart or blood vessel risk factors. Newer combinations and clinical trials are also used. For people who cannot tolerate intensive chemotherapy, a gentler approach with a TKI and less intensive treatment aims to control symptoms and extend life. Supportive care, including transfusions and treatment or prevention of infection, is part of every plan.

What to Expect

Blast phase is a serious, life-threatening stage. Without a response to treatment, survival is usually less than a year, mostly because of infections and bleeding. Outcomes depend heavily on whether the leukemia returns to chronic phase and whether a transplant is possible. Some people who reach transplant achieve long-term survival, and lymphoid blast phase tends to respond better than myeloid. The first phase of treatment typically involves a hospital stay, frequent blood tests and transfusions, and a period of very low blood counts when infection risk is high. Searching for a donor often starts right away. Transplant itself brings weeks of close care and months of recovery, with risks such as graft-versus-host disease, in which donor immune cells attack the body. For people choosing less intensive treatment, care centers on comfort, symptom control and time at home, and palliative care teams can help with both paths. Caregivers are often needed for transport, appointments and daily help during this period.

When to Seek Help

If you have CML, tell your hematologist promptly about new tiredness, fevers, drenching night sweats, unexplained weight loss, bone pain, or fullness or pain under the left ribs, or if routine tests show your response slipping. These can be early signs that the disease is changing, and earlier action gives more options. If you have trouble taking your CML medicine every day, raise it with your care team rather than stopping. During treatment for blast phase, call your care team right away, including after hours, for a fever of 100.5°F (38°C) or higher, chills or other signs of infection, because infections when blood counts are low can become life threatening quickly. Call promptly as well for unusual bleeding or bruising.

Questions to Ask Your Doctor

  1. 1.Is my blast phase myeloid or lymphoid, and did testing find mutations or chromosome changes that affect which drugs will work?
  2. 2.What is the goal of the first round of treatment, and how will we know whether the leukemia has returned to chronic phase?
  3. 3.Am I a candidate for a stem cell transplant, and should a donor search begin now?
  4. 4.Are there clinical trials for blast phase CML that would be a good fit for me?
  5. 5.If intensive treatment is not right for me, what would a less intensive plan involve and what could it achieve?

Last reviewed • Oct 2026

Educational content, not medical advice.